Nicolas Wein

1.2k total citations
34 papers, 684 citations indexed

About

Nicolas Wein is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Nicolas Wein has authored 34 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 9 papers in Genetics and 5 papers in Genetics. Recurrent topics in Nicolas Wein's work include Muscle Physiology and Disorders (25 papers), RNA Research and Splicing (9 papers) and Virus-based gene therapy research (7 papers). Nicolas Wein is often cited by papers focused on Muscle Physiology and Disorders (25 papers), RNA Research and Splicing (9 papers) and Virus-based gene therapy research (7 papers). Nicolas Wein collaborates with scholars based in United States, France and United Kingdom. Nicolas Wein's co-authors include Kevin M. Flanigan, Florian Barthélémy, Marc Bartoli, Nicolas Lévy, Martin Krahn, Lindsay N. Alfano, Adeline Vulin, Andrew R. Findlay, Nianyuan Huang and Luis Garcı́a and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and Science Translational Medicine.

In The Last Decade

Nicolas Wein

33 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Wein United States 17 639 146 134 126 87 34 684
Cécile Peccate France 15 560 0.9× 112 0.8× 86 0.6× 110 0.9× 59 0.7× 25 661
Quan Q. Gao United States 15 649 1.0× 85 0.6× 67 0.5× 116 0.9× 98 1.1× 20 749
Rachael A. Potter United States 11 581 0.9× 272 1.9× 129 1.0× 153 1.2× 54 0.6× 30 667
James S. Novak United States 14 599 0.9× 69 0.5× 92 0.7× 81 0.6× 68 0.8× 21 678
Margriet Hulsker Netherlands 11 507 0.8× 132 0.9× 48 0.4× 106 0.8× 46 0.5× 15 540
Richard J F L Lemmers Netherlands 7 539 0.8× 89 0.6× 120 0.9× 140 1.1× 81 0.9× 7 577
William Lostal France 10 442 0.7× 154 1.1× 42 0.3× 92 0.7× 48 0.6× 15 466
Ngoc Lu‐Nguyen United Kingdom 11 347 0.5× 59 0.4× 86 0.6× 64 0.5× 43 0.5× 28 392
Juergen Scharner United Kingdom 13 625 1.0× 81 0.6× 102 0.8× 46 0.4× 40 0.5× 13 712
Hiroko Wada Japan 14 461 0.7× 109 0.7× 177 1.3× 47 0.4× 36 0.4× 27 561

Countries citing papers authored by Nicolas Wein

Since Specialization
Citations

This map shows the geographic impact of Nicolas Wein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Wein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Wein more than expected).

Fields of papers citing papers by Nicolas Wein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Wein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Wein. The network helps show where Nicolas Wein may publish in the future.

Co-authorship network of co-authors of Nicolas Wein

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Wein. A scholar is included among the top collaborators of Nicolas Wein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Wein. Nicolas Wein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almeida, Camila de, Arie B. Brinkman, Christine Wendt, et al.. (2024). 471P Interfering with CUG toxic repeats using AAV.U7snRNAs rescue myotonia and splicing defects in myotonic dystrophy type 1. Neuromuscular Disorders. 43. 104441.546–104441.546.
2.
Kipp, Jingjing L., Ryan D. Roberts, Nicolas Wein, et al.. (2024). Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma. SHILAP Revista de lepidopterología. 32(4). 200908–200908. 3 indexed citations
3.
Almeida, Camila de, Nianyuan Huang, W. David Arnold, et al.. (2023). Promising AAV.U7snRNAs vectors targeting DMPK improve DM1 hallmarks in patient-derived cell lines. Frontiers in Cell and Developmental Biology. 11. 3 indexed citations
4.
Oliveira, Júlia Teixeira, et al.. (2023). Neuron-Schwann cell interactions in peripheral nervous system homeostasis, disease, and preclinical treatment. Frontiers in Cellular Neuroscience. 17. 1248922–1248922. 21 indexed citations
5.
Gushchina, Liubov V., et al.. (2023). Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model. Molecular Therapy — Methods & Clinical Development. 31. 101144–101144. 7 indexed citations
6.
Gushchina, Liubov V., Nianyuan Huang, Frederick J. Schnell, et al.. (2022). Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy. Molecular Therapy — Nucleic Acids. 30. 479–492. 9 indexed citations
7.
Dutta, Debdeep, Samantha K. Powers, Paweł Lisowski, et al.. (2022). Mechanisms of IRF2BPL-related disorders and identification of a potential therapeutic strategy. Cell Reports. 41(10). 111751–111751. 8 indexed citations
8.
Schwartz, M., et al.. (2022). Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders. Journal of Personalized Medicine. 12(12). 1979–1979. 11 indexed citations
9.
Gushchina, Liubov V., et al.. (2021). Lack of Toxicity in Nonhuman Primates Receiving Clinically Relevant Doses of an AAV9.U7snRNA Vector Designed to Induce DMD Exon 2 Skipping. Human Gene Therapy. 32(17-18). 882–894. 27 indexed citations
10.
Almeida, Camila de, Nianyuan Huang, Kim L. McBride, et al.. (2021). Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders. Journal of Visualized Experiments. 1 indexed citations
11.
Wein, Nicolas, Diane M. Dunn, Megan A. Waldrop, et al.. (2021). Absence of Significant Off-Target Splicing Variation with a U7snRNA Vector Targeting DMD Exon 2 Duplications. Human Gene Therapy. 32(21-22). 1346–1359. 13 indexed citations
12.
Wein, Nicolas, et al.. (2021). U7 snRNA, a Small RNA with a Big Impact in Gene Therapy. Human Gene Therapy. 32(21-22). 1317–1329. 13 indexed citations
13.
Wein, Nicolas, et al.. (2020). Designed U7 snRNAs inhibit DUX4 expression and improve FSHD-associated outcomes in DUX4 overexpressing cells and FSHD patient myotubes. Molecular Therapy — Nucleic Acids. 23. 476–486. 22 indexed citations
14.
Barthélémy, Inès, Nadège Calmels, Robert B. Weiss, et al.. (2020). X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation. Skeletal Muscle. 10(1). 23–23. 13 indexed citations
15.
Barthélémy, Florian & Nicolas Wein. (2018). Personalized gene and cell therapy for Duchenne Muscular Dystrophy. Neuromuscular Disorders. 28(10). 803–824. 45 indexed citations
16.
Wein, Nicolas, Lindsay N. Alfano, & Kevin M. Flanigan. (2015). Genetics and Emerging Treatments for Duchenne and Becker Muscular Dystrophy. Pediatric Clinics of North America. 62(3). 723–742. 56 indexed citations
17.
Blandin, Gaëlle, Christophe Béroud, Véronique Labelle, et al.. (2011). UMD-DYSF, a novel locus specific database for the compilation and interactive analysis of mutations in the dysferlin gene. Human Mutation. 33(3). E2317–E2331. 36 indexed citations
18.
Barthélémy, Florian, Nicolas Wein, Martin Krahn, Nicolas Lévy, & Marc Bartoli. (2011). Translational Research and Therapeutic Perspectives in Dysferlinopathies. Molecular Medicine. 17(9-10). 875–882. 30 indexed citations
19.
Wein, Nicolas, Marc Bartoli, Cyriaque Beley, et al.. (2009). Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping. Human Mutation. 31(2). 136–142. 62 indexed citations
20.
Wein, Nicolas, Marc Bartoli, Karine Nguyen, et al.. (2009). Immunolabelling and flow cytometry as new tools to explore dysferlinopathies. Neuromuscular Disorders. 20(1). 57–60. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cécile Peccate Breakdown of academic impact, for papers by Quan Q. Gao Breakdown of academic impact, for papers by Rachael A. Potter Breakdown of academic impact, for papers by James S. Novak Breakdown of academic impact, for papers by Margriet Hulsker Breakdown of academic impact, for papers by Richard J F L Lemmers Breakdown of academic impact, for papers by William Lostal Breakdown of academic impact, for papers by Ngoc Lu‐Nguyen Breakdown of academic impact, for papers by Juergen Scharner Breakdown of academic impact, for papers by Hiroko Wada
Rankless by CCL
2026